Process development


Oxford Biomedica uses its unique expertise to develop, optimise and scale-up processes from the lab through the clinic and to the market.

Our state-of-the-art laboratories have enabled the development of processes that are scalable, robust and reproducible. We have developed a serum and animal component-free suspension process, which uses chemically defined media and supplements as well as disposable single-use technologies throughout.

Our Quality-by-Design approach enables better process design through greater process understanding, product characterisation and parameter optimisation. We have adopted lean strategies to reduce development cycle times and streamline the manufacturing process.

Consequently, we are ideally positioned to ensure that the manufacturing of our products and those of our partners is commercially viable and regulatory compliant.


  • Maximises yield, recovery, throughput and improves product quality
  • Increases speed-to-clinic and speed-to-market
  • Scalable process to meet current and future market demand
  • Enables better process control and reduces process variability